Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of High Risk Central Nervous System Embryonal Tumors With Conventional Radiotherapy and Intensive Consolidation Chemotherapy With Peripheral Blood Progenitor Cell (PBSC) Support

NCT00003846 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00003846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of High Risk Central Nervous System Embryonal Tumors With Conventional Radiotherapy and Intensive Consolidation Chemotherapy With Peripheral Blood Progenitor Cell (PBSC) Support
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
July 31, 1999
Completion date
March 31, 2007
Enrollment
25 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, neuroblastoma